Astal Laboratories Ltd vs Supriya Lifescience Ltd Stock Comparison
Astal Laboratories Ltd vs Supriya Lifescience Ltd Stock Comparison
Last Updated on: May 04, 2026
Key Highlights
The Latest Trading Price of Astal Laboratories Ltd is ₹ 62.13 as of 30 Apr 15:30
. The P/E Ratio of Astal Laboratories Ltd changed from 437.5 on March 2021 to 8.4 on March 2025 . This represents a CAGR of -54.64% over 5 yearsThe P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 31.4 on March 2025 . This represents a CAGR of 4.73% over 4 years The Market Cap of Astal Laboratories Ltd changed from ₹ 3.47 crore on March 2021 to ₹ 74.72 crore on March 2025 . This represents a CAGR of 84.77% over 5 yearsThe Market Cap of Supriya Lifescience Ltd changed from ₹ 3967 crore on March 2022 to ₹ 5903 crore on March 2025 . This represents a CAGR of 10.45% over 4 years The revenue of Astal Laboratories Ltd for the Dec '25 is ₹ 52.27 crore as compare to the Sep '25 revenue of ₹ 37.55 crore. This represent the growth of 39.2% The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 209.05 crore as compare to the Sep '25 revenue of ₹ 202.56 crore. This represent the growth of 3.2% The ebitda of Astal Laboratories Ltd for the Dec '25 is ₹ 3.59 crore as compare to the Sep '25 ebitda of ₹ 3.9 crore. This represent the decline of -7.95% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 74.24 crore as compare to the Sep '25 ebitda of ₹ 75.37 crore. This represent the decline of -1.5% The net profit of Astal Laboratories Ltd changed from ₹ 1.69 crore to ₹ 2.36 crore over 7 quarters. This represents a CAGR of 21.02%
The net profit of Supriya Lifescience Ltd changed from ₹ 44.64 crore to ₹ 49.68 crore over 7 quarters. This represents a CAGR of 6.30%
The Dividend Payout of Astal Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 years .
About Astal Laboratories Ltd
Astal Laboratories Limited was formerly incorporated as a public company limited by shares on August 03, 1993 in the name of Macro International Limited.
The Company was taken over under SEBI takeover guidelines in 2022 and the main objects of the Company was changed to 'Manufacture and Sales of Pharmaceutical Intermediates and Bulk Drugs'.
Subsequently the name of the Company was changed to Astal Laboratories Limited in May, 2024.
The Company is now a subsidiary of Aceso Research Labs LLP.
The Company was promoted by the Kanpur based business house of Parasrampurias.
The Company set up a departmental store at Plaza Kalpana, Birhana Road, Kanpur, offering products such as readymade garments, electronic items, leather items, stationery, books, fast food centre etc.
During 1996-97, the departmental store project succeeded, only Saree Division and Archies Card Division was in operation.
About Supriya Lifescience Ltd
Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai.
The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.
FAQs for the comparison of Astal Laboratories Ltd and Supriya Lifescience Ltd
Which company has a larger market capitalization, Astal Laboratories Ltd or Supriya Lifescience Ltd?
Market cap of Astal Laboratories Ltd is 262 Cr while Market cap of Supriya Lifescience Ltd is 5,589 Cr
What are the key factors driving the stock performance of Astal Laboratories Ltd and Supriya Lifescience Ltd?
The stock performance of Astal Laboratories Ltd and Supriya Lifescience Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Astal Laboratories Ltd and Supriya Lifescience Ltd?
As of May 4, 2026, the Astal Laboratories Ltd stock price is INR ₹62.13. On the other hand, Supriya Lifescience Ltd stock price is INR ₹694.5.
How do dividend payouts of Astal Laboratories Ltd and Supriya Lifescience Ltd compare?
To compare the dividend payouts of Astal Laboratories Ltd and Supriya Lifescience Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.